HB 2050

  • Pennsylvania House Bill
  • 2021-2022 Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

An Act providing for the regulation of cannabis and cannabis products for personal use and for exemptions related to the personal use of cannabis and cannabis products; establishing a cannabis regulatory control board and providing for its powers, duties and restrictions; conferring powers and imposing duties on the Department of Revenue, the Department of Agriculture, the Department of Health and the Office of Attorney General; regulating the cultivation, processing, distribution, testing, transporting, sale and offering for sale of cannabis and cannabis products; providing for licensing and permitting of cannabis entities, cannabis microbusinesses, cannabis testing laboratories and other persons engaged in a regulated activity, for certification or registration of essential employees, officers, principals and other persons and for social and economic equity; establishing the Office of Social and Economic Equity and the Cannabis Business Development Fund; providing for diverse business development and a grant and loan program; establishing the Cannabis Revenue Fund; providing for Communities Reimagined and Reinvestment Program, for Community Reimagined and Reinvestment Account and for Substance Abuse Prevention, Treatment and Education Fund; imposing fees, taxes and assessments on cannabis entity licensees, permittees and persons engaged in a regulated activity; and providing for enforcement, for prohibited acts, for penalties, for sanctions and immunities, for certain expungements, for transfer of functions of the Department of Health and for medical marijuana.


No votes to display


Oct 27, 2021


PN 2333 Referred to JUDICIARY

Bill Text

Bill Text Versions Format
Printer's No. 2333 MSWORD PDF HTML

Related Documents

Document Format
No related documents.


Data on Open States is updated periodically throughout the day from the official website of the Pennsylvania General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.